In my experience theres a reason patients increase their doses as recommended: they simply dont lose enough weight on the starting doses
One systematic review of the various adverse reactions of GLP-1s alleged that while side effects of semaglutide and tirzepatide are dose-dependent, ...dose escalation could not rise the concurrent rates of [hypoglycemia]... Worth noting: Dose escalation and double-dosing are not the same thing
At this point, you're probably curious about GLP-1 Treatments, Semaglutide or Tirzepatide weight loss and how the medicine is so effective
Do not use the pen if a drop of Ozempic still does not appear
Higher doses come with more pronounced GI side effects , and the incremental weight loss benefit diminishes at each step up
Importantly, the FDA labels for semaglutide products note that these medications have not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and are not recommended for use in these populations